[Polyarthralgia disclosing hyperthyroidism. Two case reports].

Presse Med

Service de Médecine interne, Hôpital d'Instruction des Armées Sainte-Anne, Toulon Naval.

Published: September 1998

Background: We report two cases of rheumatism associated with hyperthyroidism. In both cases, arthralgia totally regressed after thyroid treatment.

Case Reports: Two 79-year-old and 59-year-old women developed manifestations of polymyalgia rheumatica and psoriasis arthritis respectively. Corticosteroid therapy was ineffective and followed by manifestations of hyperthyroidism. The first patient was treated with carbimazole and the second with thyroidectomy. Once the hyperthyroidism was controlled, both patients experienced a dramatically rapid cure of their arthralgias.

Discussion: Scalpulo-humeral periarthritis is the main articular complication of hyperthyroidism. True manifestations of "thyrotoxicosis rheumatism" are unusual and may be linked with a direct toxicity of the thyroid hormones on joint cartilage or with an autoimmune manifestation of hyperthyroidism.

Download full-text PDF

Source

Publication Analysis

Top Keywords

hyperthyroidism
6
[polyarthralgia disclosing
4
disclosing hyperthyroidism
4
hyperthyroidism case
4
case reports]
4
reports] background
4
background report
4
report cases
4
cases rheumatism
4
rheumatism associated
4

Similar Publications

Antithyroid drugs can cause neutropenia or agranulocytosis, rarely pancytopenia in hyperthyroidism therapy. The treatment is difficult and lethality is high when granulocytopenia or pancytopenia combined with hyperthyroidism crisis. First Affiliated Hospital of Army Medical University treated a patient who had pancytopenia caused by methimazole with systemic lupus erythematosus, secondary hyperthyroidism crisis and agranulocytosis.

View Article and Find Full Text PDF

Treatment of Hyperthyroidism in Graves' Disease Complicated by Thyroid Eye Disease.

J Clin Endocrinol Metab

January 2025

Department of Ophthalmology and Visual Sciences and Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48105  USA.

Thyroid eye disease (TED) is the most consequential extrathyroidal manifestation or complication of Graves' disease (GD). Treatment of hyperthyroidism in GD complicated by TED is challenging. Antithyroid drugs (ATDs) and thyroidectomy do not change the natural course of TED, while radioactive iodine (RAI) is associated with a small but well-documented risk of TED de novo occurrence or its progression/worsening.

View Article and Find Full Text PDF

Public Health.

Alzheimers Dement

December 2024

Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy.

Background: Overt hyperthyroidism and hypothyroidism are regarded as possible causes of reversible dementia. Evidence on the risk of dementia associated with subclinical thyroid dysfunctions is limited and barely existent in the very old, while findings are conflicting.

Objective: To cross-sectionally and longitudinally investigate the association of subclinical-hyperthyroidism and subclinical-hypothyroidism with dementia in a prospective population-based study of 80-years or older residents in Varese province, Italy (Monzino 80-plus Study).

View Article and Find Full Text PDF

Evaluation of a point-of-care test for quantitative determination of total thyroxine in feline serum.

J Feline Med Surg

January 2025

Department of Veterinary Medicine and Animal Sciences (DIVAS), University of Milan, Lodi (LO), Italy.

Objectives: Total thyroxine (TT4) evaluation is the most commonly used first-line test for the diagnosis and monitoring of cats with hyperthyroidism. Vcheck T4 is a point-of-care immunoassay that measures TT4 using a Vcheck V200 analyser. This study aimed to evaluate the analytic performance of the Vcheck T4 assay in feline sera and the agreement in the classification of normal, high and low TT4 concentrations of Vcheck T4 with those measured by an enzyme immunoassay (EIA).

View Article and Find Full Text PDF

Mendelian randomization (MR) was employed to investigate the causal relationships between immune cell phenotypes, hyperthyroidism (HD), and potential metabolic mediators. In this study, we acquired 731 immune cell phenotypes from genome-wide association studies (GWAS) (n = 18,622), HD data from the research by Handan Melike Dönertaş et al. (3,731 cases, 480,867 controls), and aggregated statistics of 1,400 blood metabolites from UK Biobank (n = 115,078).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!